These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25546914)

  • 21. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
    Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J
    Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
    Kalb R; Kram R; Morgera S; Slowinski T; Kindgen-Milles D
    Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of the HepZero study comparing heparin-grafted membrane and standard care show that heparin-grafted dialyzer is safe and easy to use for heparin-free dialysis.
    Laville M; Dorval M; Fort Ros J; Fay R; Cridlig J; Nortier JL; Juillard L; Dębska-Ślizień A; Fernández Lorente L; Thibaudin D; Franssen C; Schulz M; Moureau F; Loughraieb N; Rossignol P
    Kidney Int; 2014 Dec; 86(6):1260-7. PubMed ID: 25007166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The risk of bleeding associated with low molecular weight heparin in patients with renal failure].
    Lai S; Barbano B; Cianci R; Gigante A; Di Donato D; Asllanaj B; Dimko M; Mariotti A; Morabito S; Pugliese F
    G Ital Nefrol; 2010; 27(6):649-54. PubMed ID: 21132647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of a sliding scale protocol for heparin on the ability to maintain whole blood activated partial thromboplastin times within a desired range in hemodialysis patients.
    Low CL; Bailie G; Morgan S; Eisele G
    Clin Nephrol; 1996 Feb; 45(2):120-4. PubMed ID: 8846524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Granulocyte activation during hemodialysis.
    Hörl WH; Riegel W; Steinhauer HB; Wanner C; Thaiss F; Bozkurt F; Haag M; Schollmeyer P
    Clin Nephrol; 1986; 26 Suppl 1():S30-4. PubMed ID: 3829465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-dilution hemodiafiltration with a heparin-grafted polyacrylonitrile membrane.
    Frascà GM; Sagripanti S; D'Arezzo M; Oliva S; Francioso A; Mosconi G; Zambianchi L; Sopranzi F; Boggi R; Fattori L; Rigotti A; Maldini L; Gattiani A; Del Rosso G; Federico A; Da Lio L; Ferrante L
    Ther Apher Dial; 2015 Apr; 19(2):154-61. PubMed ID: 25257219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unfractionated heparin for hemodialysis: still the best option.
    Cronin RE; Reilly RF
    Semin Dial; 2010; 23(5):510-5. PubMed ID: 21039876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of the hemodialysis adequacy conducted based on low-flux polysulfone dialyzers and high-flux helixone dialyzers].
    Sobaszek-Pitas M; Kopeć J; Krzanowski M; Sułowicz W
    Przegl Lek; 2014; 71(7):384-8. PubMed ID: 25338334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The safety of heparins in end-stage renal disease.
    Sonawane S; Kasbekar N; Berns JS
    Semin Dial; 2006; 19(4):305-10. PubMed ID: 16893408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparin albumin priming in a clinical setting for hemodialysis patients at risk for bleeding.
    Skagerlind M; Stegmayr B
    Hemodial Int; 2017 Apr; 21(2):180-189. PubMed ID: 27576541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparin-coated hemodialyzers--the holy grail for patients at risk of bleeding?
    Evenepoel P
    Nephron Clin Pract; 2004; 97(1):c1-2. PubMed ID: 15153759
    [No Abstract]   [Full Text] [Related]  

  • 33. Low thrombogenicity of polyethylene glycol-grafted cellulose membranes does not influence heparin requirements in hemodialysis.
    Wright MJ; Woodrow G; Umpleby S; Hull S; Brownjohn AM; Turney JH
    Am J Kidney Dis; 1999 Jul; 34(1):36-42. PubMed ID: 10401013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin-coated dialyzer membranes: is non-inferiority good enough?
    Meijers BK; Poesen R; Evenepoel P
    Kidney Int; 2014 Dec; 86(6):1084-6. PubMed ID: 25427085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). The first long-term application of r-hirudin in a haemodialysis patient.
    Nowak G; Bucha E; Brauns I; Czerwinski R
    Wien Klin Wochenschr; 1997 May; 109(10):354-8. PubMed ID: 9200807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimization of heparin anticoagulation for hemodialysis.
    Davenport A
    Hemodial Int; 2011 Oct; 15 Suppl 1():S43-8. PubMed ID: 22093600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of citrate-enriched bicarbonate based dialysate on anticoagulation and dialyzer reuse in maintenance hemodialysis patients.
    Rocha AD; Padua VC; Oliveira E; Guimaraes MM; Lugon JR; Strogoff de Matos JP
    Hemodial Int; 2014 Apr; 18(2):467-72. PubMed ID: 24261328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin-free hemodialysis with a polyacrylonitrile membrane.
    Barth RH; Sodden S; Berlyne GM
    ASAIO Trans; 1989; 35(3):597-600. PubMed ID: 2597544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A heparin-coated dialysis filter (AN69 ST) does not reduce clotting during hemodialysis when compared to a conventional polysulfone filter (F×8).
    Sagedal S; Witczak BJ; Osnes K; Hartmann A; Os I; Eikvar L; Klingenberg O; Brosstad F
    Blood Purif; 2011; 32(3):151-5. PubMed ID: 21659742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved dialyzer reuse after use of a population pharmacodynamic model to determine heparin doses.
    Ouseph R; Brier ME; Ward RA
    Am J Kidney Dis; 2000 Jan; 35(1):89-94. PubMed ID: 10620549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.